The lipid-lowering drug fenofibrate could be a useful adjunctive treatment for preventing gout in patients with type 2 diabetes, an Australian trial has shown. Use of fenobibrate reduced uric acid levels by 20% and almost halved incident gout events, a retrospective analysis of a trial involving almost 10,000 patients with type 2 diabetes has found. ...
Lipid lowering drug has gout prevention benefit, FIELD trial reveals
By Michael Woodhead
9 Mar 2018